The Full Wiki

More info on Integrin alpha M

Integrin alpha M: Wikis

Advertisements
  

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

edit
Integrin, alpha M (complement component 3 receptor 3 subunit)

PDB rendering based on 1bho.
Available structures
1bho, 1bhq, 1idn, 1ido, 1jlm, 1m1u, 1mf7, 1n9z, 1na5
Identifiers
Symbols ITGAM; CD11B; CR3A; MAC-1; MAC1A; MGC117044; MO1A
External IDs OMIM120980 MGI96607 HomoloGene526 GeneCards: ITGAM Gene
RNA expression pattern
PBB GE ITGAM 205786 s at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 3684 16409
Ensembl ENSG00000169896 ENSMUSG00000030786
UniProt P11215 A1E2I0
RefSeq (mRNA) NM_000632 NM_008401
RefSeq (protein) NP_000623 NP_032427
Location (UCSC) Chr 16:
31.18 - 31.25 Mb
Chr 7:
127.85 - 127.92 Mb
PubMed search [1] [2]

Integrin alpha M (ITGAM) is one protein subunit that forms the heterodimeric integrin alpha-M beta-2 (αMβ2) molecule, also known as macrophage-1 antigen (Mac-1) or complement receptor 3 (CR3).[1] ITGAM is also known as CR3A, and cluster of differentiation molecule 11B (CD11B). The second chain of αMβ2 is the common integrin β2 subunit known as CD18, and integrin αMβ2 thus belongs to the β2 subfamily (or leukocyte) integrins.[2]

αMβ2 is expressed on the surface of many leukocytes involved in the innate immune system, including monocytes, granulocytes, macrophages, and natural killer cells.[1] It mediates inflammation by regulating leukocyte adhesion and migration and has been implicated in several immune processes such as phagocytosis, cell-mediated cytotoxicity, chemotaxis and cellular activation.[1] It is involved in the complement system due to its capacity to bind inactivated complement component 3b (iC3b).[3] The ITGAM (alpha) subunit of integrin αMβ2 is directly involved in causing the adhesion and spreading of cells but cannot mediate cellular migration without the presence of the β2 (CD18) subunit.[1]

In genomewide association studies, single nucleotide polymorphisms in ITGAM had the strongest association with systemic lupus erythematosus, with an odds ratio of 1.65 for the T allele of rs9888739 and lupus.[4][5]

Contents

See also

References

  1. ^ a b c d Solovjov D, Pluskota E, Plow E (2005). "Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2". J Biol Chem 280 (2): 1336–45. doi:10.1074/jbc.M406968200. PMID 15485828.  
  2. ^ Larson R, Springer T (1990). "Structure and function of leukocyte integrins". Immunol Rev 114: 181–217. doi:10.1111/j.1600-065X.1990.tb00565.x. PMID 2196220.  
  3. ^ Arnaout M, Todd R, Dana N, Melamed J, Schlossman S, Colten H (1983). "Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol)". J Clin Invest 72 (1): 171–9. doi:10.1172/JCI110955. PMID 6874946.  
  4. ^ Mary K. Crow (February 28, 2008). "Collaboration, Genetic Associations, and Lupus Erythematosus". N Engl J Med 358 (9): 956–961. doi:10.1056/NEJMe0800096. PMID 18204099. http://content.nejm.org/cgi/content/full/358/9/956.  
  5. ^ Geoffrey Hom, Robert R. Graham, Barmak Modrek, et al. (February 28, 2008). "Association of Systemic Lupus Erythematosus with C8orf13–BLK and ITGAM–ITGAX". N Engl J Med 358 (9): 900–909. doi:10.1056/NEJMoa0707865. PMID 18204098. http://content.nejm.org/cgi/content/full/358/9/900.  

Further reading

  • Stewart M, Thiel M, Hogg N (1996). "Leukocyte integrins.". Curr. Opin. Cell Biol. 7 (5): 690–6. doi:10.1016/0955-0674(95)80111-1. PMID 8573344.  
  • Todd RF, Petty HR (1997). "Beta 2 (CD11/CD18) integrins can serve as signaling partners for other leukocyte receptors.". J. Lab. Clin. Med. 129 (5): 492–8. doi:10.1016/S0022-2143(97)90003-2. PMID 9142045.  
  • Schymeinsky J, Mócsai A, Walzog B (2007). "Neutrophil activation via beta2 integrins (CD11/CD18): molecular mechanisms and clinical implications.". Thromb. Haemost. 98 (2): 262–73. PMID 17721605.  

External links

Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message